Proc Natl Acad Sci USA 2004,101(39):14240–14245.Selleckchem GDC 973 PubMedCrossRef 20. Arun S, Neubauer H, Gurel A, Ayyildiz G, Kuscu B, Yesildere T, Meyer H, Hermanns W: Equine glanders in Turkey. Vet Rec 1999,144(10):255–258.PubMedCrossRef 21. Neubauer H, Meyer H, Finke EJ: Human glanders. Revue Internationale des Services de Sante des Forces Armees 1997, 70:258–265. 22. Whitlock GC, Estes DM, Torres AG: Glanders: off to the races with Burkholderia mallei. FEMS Microbiol Lett 2007,277(2):115–122.PubMedCrossRef

23. Srinivasan A, Kraus CN, DeShazer D, Becker PM, Dick JD, Spacek L, Bartlett JG, Byrne WR, Thomas DL: Glanders in a military research microbiologist. N Engl J Med 2001,345(4):256–258.PubMedCrossRef 24. Gregory BC, Waag DM: Glanders. In Medical Aspects of Biological Idasanutlin solubility dmso Warfare. U.S Army Medical Department Borden Insitute Textbooks of Biological Warfare; 2007:121–146. 25. Waag DM, Deshazer D: Glanders: New insights into an old disease. In Biological Weapons Defense: Infectious Diseases and Counterbioterrorism. Edited by: Lindler LE LF,

Korch GW. Totowa, New Jersey: Humana Press Inc; 2004. 26. Nierman WC, DeShazer D, Kim HS, Tettelin H, Nelson KE, Feldblyum GSK2118436 in vivo T, Ulrich RL, Ronning CM, Brinkac LM, Daugherty SC, Davidsen TD, Deboy RT, Dimitrov G, Dodson RJ, Durkin AS, Gwinn ML, Haft DH, Khouri H, Kolonay JF, Madupu R, Mohammoud Y, Nelson WC, Radune D, Romero CM, Sarria S, Selengut J, Shamblin C, Sullivan SA, White O, Yu Y, Zafar N, Zhou L, Fraser CM: Structural flexibility in the Burkholderia mallei genome. Proc Natl Acad Sci USA 2004,101(39):14246–14251.PubMedCrossRef 27. Kumar A, Chua KL, Schweizer HP: Method for regulated expression of single-copy efflux pump

genes in a surrogate Pseudomonas aeruginosa strain: identification of the BpeEF-OprC chloramphenicol and trimethoprim efflux pump of Burkholderia pseudomallei 1026b. Antimicrob Agents Chemother 2006,50(10):3460–3463.PubMedCrossRef 28. Harland DN, Dassa E, Titball RW, Brown KA, Atkins HS: ATP-binding cassette systems in Burkholderia pseudomallei and Burkholderia mallei. BMC Genomics 2007, 8:83.PubMedCrossRef RVX-208 29. Tribuddharat C, Moore RA, Baker P, Woods DE: Burkholderia pseudomallei class a beta-lactamase mutations that confer selective resistance against ceftazidime or clavulanic acid inhibition. Antimicrob Agents Chemother 2003,47(7):2082–2087.PubMedCrossRef 30. Dance DA, Wuthiekanun V, Chaowagul W, White NJ: The antimicrobial susceptibility of Pseudomonas pseudomallei. Emergence of resistance in vitro and during treatment. J Antimicrob Chemother 1989,24(3):295–309.PubMedCrossRef 31. Jenney AW, Lum G, Fisher DA, Currie BJ: Antibiotic susceptibility of Burkholderia pseudomallei from tropical northern Australia and implications for therapy of melioidosis. Int J Antimicrob Agents 2001,17(2):109–113.PubMedCrossRef 32.